Primary Central Nervous System Vasculitis Following Alemtuzumab Treatment for Multiple Sclerosis A Case Report and Literature Review

被引:1
作者
Varela, Lucia [1 ]
Pappolla, Agustin [3 ]
Heriz, Alejandra [1 ]
Marquez, Rocio [1 ]
Vega, Otto [1 ]
Christiansen, Silvia [2 ]
Rugiero, Marcelo [1 ]
Midaglia, Luciana [3 ]
Salerno, Annalaura [4 ,5 ]
Tintore, Mar [3 ]
Rovira, Alex [4 ,5 ]
机构
[1] Italian Hosp Buenos Aires, Dept Neurol, Buenos Aires, DF, Argentina
[2] Italian Hosp Buenos Aires, Dept Pathol, Buenos Aires, DF, Argentina
[3] Vall dHebron Barcelona Hosp Campus, Multiple Sclerosis Ctr Catalonia Cemcat, Barcelona 08035, Spain
[4] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Sect Neuroradiol, Dept Radiol IDI,Vall dHebron Inst Recerca, Barcelona, Spain
[5] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Magnet Resonance Unit, Dept Radiol IDI,Vall dHebron Inst Recerca, Barcelona, Spain
关键词
alemtuzumab; multiple sclerosis; seizure; central nervous system vasculitis; encephalitis;
D O I
10.1097/NRL.0000000000000480
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction:Cerebral vasculitides are often devastating conditions that require immediate diagnosis and treatment. Case report:We report a pathologically proven clinical case of primary central nervous system vasculitis in a 50-year-old man with a diagnosis of relapsing-remitting multiple sclerosis after alemtuzumab therapy, which required additional immunosuppression to control this life-threatening condition. Conclusion:In patients presenting subacute neurological deterioration after alemtuzumab therapy, primary central nervous system vasculitis should be considered as a differential diagnosis among other autoimmune conditions.
引用
收藏
页码:270 / 272
页数:3
相关论文
共 50 条
  • [11] Autoimmune encephalitis following alemtuzumab treatment of multiple sclerosis
    Giarola, Blake
    Massey, Jennifer
    Barnett, Yael
    Rodrigues, Michael
    Sutton, Ian
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 28 : 31 - 33
  • [12] Primary central nervous system tumors in patients with multiple sclerosis
    Masih Sabouri
    Masoud Etemadifar
    Fatemeh Dehghani Firoozabadi
    Setayesh Sindarreh
    Amirhossein Akhavan-Sigari
    BMC Neurology, 25 (1)
  • [13] Autoimmune thyroid disease following treatment with alemtuzumab for multiple sclerosis
    Alamo, Angela
    Condorelli, Rosita A.
    La Vignera, Sandro
    Calogero, Aldo E.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2019, 33
  • [14] The coincidence of multiple sclerosis and primary vasculitis; from the bench of pathology to the bedside of treatment: a systematic review of case reports
    Bafrani, Melika Arab
    Asadigandomani, Hassan
    Kasbi, Naghmeh Abbasi
    Heidari, Hora
    Eskandarieh, Sharareh
    NEUROLOGICAL SCIENCES, 2025, 46 (01) : 351 - 364
  • [15] Product review on MAbs (alemtuzumab and ocrelizumab) for the treatment of multiple sclerosis
    Gabelic, Tereza
    Barun, Barbara
    Adamec, Ivan
    Krbot Skoric, Magdalena
    Habek, Mario
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (11) : 4345 - 4362
  • [16] Susceptibility-weighted imaging in the differential diagnosis of autoimmune central nervous system vasculitis and multiple sclerosis
    Huang Xuehong
    Lu Tingting
    Guo Zhuoxin
    Wei Lei
    Chen Shaoqiong
    Qiu Wei
    Lu Zhengqi
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 33 : 70 - 74
  • [17] Case report of anti-glomerular basement membrane disease following alemtuzumab treatment of relapsing-remitting multiple sclerosis
    Meyer, David
    Coles, Alasdair
    Oyuela, Pedro
    Purvis, Annie
    Margolin, David H.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2013, 2 (01) : 60 - 63
  • [18] An unforeseen reality: Hemophagocytic lymphohistiocytosis following alemtuzumab treatment for a multiple sclerosis
    Osep, Anka Blagotinsek
    Brecl, Eva
    Skerget, Matevz
    Savsek, Lina
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2023, 228
  • [19] Acquired haemophilia A as a secondary autoimmune disease after alemtuzumab treatment in multiple sclerosis: A case report
    Pisa, M.
    Della Valle, P.
    Coluccia, A.
    Martinelli, V.
    Comi, G.
    D'Angelo, A.
    Moiola, L.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 27 : 403 - 405
  • [20] Cerebral haemorrhage in the presence of primary childhood central nervous system vasculitis—a review
    Karin Pistracher
    Verena Gellner
    Stefan Riegler
    Bernadette Schökler
    Michael Scarpatetti
    Senta Kurschel
    Child's Nervous System, 2012, 28 : 1141 - 1148